These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33015157)

  • 1. Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis.
    Saavedra N; Rojas G; Herrera J; Rebolledo C; Ruedlinger J; Bustos L; Bobadilla B; Pérez L; Saavedra K; Zambrano T; Lanas F; Salazar LA
    Biomed Res Int; 2020; 2020():2509039. PubMed ID: 33015157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating level of microRNA-142-5p is a potential biomarker for predicting in-stent restenosis: a case-control study.
    Pan CH; Chien SC; Chen CJ; Shih CM; Hsieh MH; Huang CY; Bi WF; Chan CS; Kao YT; Hsiao CY; Chiang SJ; Chiang KH; Huang JH; Liu YR; Luo JD; Huang HY; Wu CH
    BMC Cardiovasc Disord; 2021 Feb; 21(1):77. PubMed ID: 33557763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis.
    He M; Gong Y; Shi J; Pan Z; Zou H; Sun D; Tu X; Tan X; Li J; Li W; Liu B; Xue J; Sheng L; Xiu C; Yang N; Xue H; Ding X; Yu C; Li Y
    PLoS One; 2014; 9(11):e112043. PubMed ID: 25427155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Circulating microRNAs for In-Stent Restenosis in Patients with Lower Extremity Arterial Occlusive Disease.
    Yuan L; Dong J; Zhu G; Bao J; Lu Q; Zhou J; Jing Z
    Sci Rep; 2019 Feb; 9(1):1402. PubMed ID: 30718561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially expressed miR-152, a potential biomarker for in-stent restenosis (ISR) in peripheral blood mononuclear cells (PBMCs) of coronary artery disease (CAD) patients.
    Maheronnaghsh M; Niktab I; Enayati S; Amoli MM; Hosseini SK; Tavakkoly-Bazzaz J
    Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1137-1147. PubMed ID: 33712363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of circulating pro-angiogenic microRNA expressions as biomarkers for rapid angiographic stenotic progression and restenosis risks in coronary artery disease patients underwent percutaneous coronary intervention.
    Dai R; Liu Y; Zhou Y; Xiong X; Zhou W; Li W; Zhou W; Chen M
    J Clin Lab Anal; 2020 Jan; 34(1):e23013. PubMed ID: 31495986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease.
    Yu ZH; Wang HT; Tu C
    Eur J Med Res; 2017 Jan; 22(1):2. PubMed ID: 28057086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
    He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of miRNA-1,miRNA-21 in plasma on in-stent restenosis in patients with coronary heart disease and diabetes mellitus after percutaneous coronary intervention].
    Guan JJ; Zhang Y; Liu YJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Apr; 34(4):304-308 384. PubMed ID: 30788936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions.
    Hibbert B; Chen YX; O'Brien ER
    Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H518-24. PubMed ID: 15277195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease.
    Li H; Gao F; Wang X; Wu J; Lu K; Liu M; Li R; Ding L; Wang R
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064817
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
    Tesche C; De Cecco CN; Vliegenthart R; Duguay TM; Stubenrauch AC; Rosenberg RD; Varga-Szemes A; Bayer RR; Yang J; Ebersberger U; Baquet M; Jochheim D; Hoffmann E; Steinberg DH; Chiaramida SA; Schoepf UJ
    J Cardiovasc Comput Tomogr; 2016; 10(5):377-83. PubMed ID: 27431607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum TREM-1 level is associated with in-stent restenosis, and activation of TREM-1 promotes inflammation, proliferation and migration in vascular smooth muscle cells.
    Wang F; Li C; Ding FH; Shen Y; Gao J; Liu ZH; Chen JW; Zhang RY; Shen WF; Wang XQ; Lu L
    Atherosclerosis; 2017 Dec; 267():10-18. PubMed ID: 29080545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active matrix metalloproteinases 3 and 9 are independently associated with coronary artery in-stent restenosis.
    Jones GT; Tarr GP; Phillips LV; Wilkins GT; van Rij AM; Williams MJ
    Atherosclerosis; 2009 Dec; 207(2):603-7. PubMed ID: 19576586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of coronary collateral circulation on angiographic in-stent restenosis in patients with stable coronary artery disease and chronic total occlusion.
    Yang ZK; Shen Y; Hu J; Zhang Q; Ding FH; Zhang RY; Lu L; Shen WF
    Int J Cardiol; 2017 Jan; 227():485-489. PubMed ID: 27836292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA-21 as Stable Blood-Based Markers for Patients With ISR After PCI.
    Zhang X; Xiao XP; Ren XA; Xue W
    Heart Surg Forum; 2020 Oct; 23(6):E756-E762. PubMed ID: 33234202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Small Extracellular Vesicle-Carried miRNA-501-5p Promotes Vascular Smooth Muscle Cell Phenotypic Modulation-Mediated In-Stent Restenosis.
    Gao XF; Wang ZM; Chen AQ; Wang F; Luo S; Gu Y; Kong XQ; Zuo GF; Jiang XM; Ding GW; Chen Y; Ge Z; Zhang JJ; Chen SL
    Oxid Med Cell Longev; 2021; 2021():6644970. PubMed ID: 33968296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis. Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial.
    Alfonso F; Cequier A; Angel J; Martí V; Zueco J; Bethencourt A; Mantilla R; López-Minguez JR; Gómez-Recio M; Morís C; Perez-Vizcayno MJ; Fernández C; Macaya C; Seabra-Gomes R;
    Am Heart J; 2006 Mar; 151(3):681.e1-681.e9. PubMed ID: 16504631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated level of miR-17 along with decreased levels of TIMP-1 and IL-6 in plasma associated with the risk of in-stent restenosis.
    Jiang F; Zhang X; Lu YM; Li YG; Zhou X; Wang YS
    Biosci Trends; 2019 Nov; 13(5):423-429. PubMed ID: 31666440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.